Cleared Traditional

K222925 - Hypodermic Syringes & Needle (FDA 510(k) Clearance)

Jul 2023
Decision
295d
Days
Class 2
Risk

K222925 is an FDA 510(k) clearance for the Hypodermic Syringes & Needle. This device is classified as a Syringe, Piston (Class II - Special Controls, product code FMF).

Submitted by Lifelong Meditech Private Limited (Gurgaon, IN). The FDA issued a Cleared decision on July 18, 2023, 295 days after receiving the submission on September 26, 2022.

This device falls under the General Hospital FDA review panel. Regulated under 21 CFR 880.5860.

Submission Details

510(k) Number K222925 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 26, 2022
Decision Date July 18, 2023
Days to Decision 295 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF

Device Classification

Product Code FMF - Syringe, Piston
Device Class Class II - Special Controls
CFR Regulation 21 CFR 880.5860

Similar Devices - FMF Syringe, Piston

All 22
Profoject™ Insulin Syringes
K253068 · CMT Health PTE., Ltd. · Feb 2026
Instylla Delivery Kit
K253769 · Instylla, Inc. · Dec 2025
Verisafe Safety Retractable Insulin Syringes
K250192 · Promisemed Hangzhou Meditech Co., Ltd. · Dec 2025
Merit Syringe
K250853 · Merit Medical Systems, Inc. · Nov 2025
Monoject™ 1mL Tuberculin Syringe Luer-Lock Tip (1180100777)
K243660 · Cardinalhealth · Aug 2025
BD Plastipak™ Syringe
K251350 · Becton, Dickinson and Company · Jul 2025